Warning: This security is no longer trading.
defunct
Novelion Therapeutics Inc. (NVLN): Price and Financial Metrics
NVLN Price/Volume Stats
| Current price | $0.68 | 52-week high | $2.35 |
| Prev. close | $0.70 | 52-week low | $0.54 |
| Day low | $0.54 | Volume | 238,300 |
| Day high | $0.68 | Avg. volume | 190,529 |
| 50-day MA | $0.72 | Dividend yield | N/A |
| 200-day MA | $0.98 | Market Cap | 13.34M |
NVLN Stock Price Chart Interactive Chart >
Novelion Therapeutics Inc. (NVLN) Company Bio
Novelion Therapeutics is a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare diseases. The company seeks to advance its portfolio of rare disease therapies by investing in science and clinical development. Novelion has a diversified commercial portfolio through its indirect subsidiary, Aegerion Pharmaceuticals, Inc., which includes MYALEPT® and JUXTAPID®, and is also developing zuretinol acetate for the treatment of inherited retinal disease caused by underlying mutations in RPE65 or LRAT genes.
NVLN Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | -49.25% |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | 0.00% |
Loading social stream, please wait...